Altri (ALTR) Q2 2026 earnings summary

Executive summary

• Total revenues in 2Q26 reached €204.6M, up 20.8% year-over-year, driven by higher sales volumes and strong growth in dissolving pulp (DP) sales (+92.8%).

• EBITDA for 2Q26 was €30.0M, up 6.5% year-over-year, with a margin of 14.7%. Net profit rose to €12.9M from €6.4M in 2Q25.

• Operational recovery followed adverse weather in 1Q26, with normalization of logistics and production.

• Strategic projects advanced, including Biotek’s DP conversion and Caima’s acetic acid/furfural project.

Financial highlights

• 2Q26 revenues: €204.6M (+20.8% YoY, +27.7% QoQ); EBITDA: €30.0M (+6.5% YoY, nearly 6x QoQ); EBITDA margin: 14.7% (down 2.0 p.p. YoY, up 11.3 p.p. QoQ).

• Net profit in 2Q26: €12.9M (vs. €6.4M in 2Q25, €-7.3M in 1Q26).

• 1H26 revenues: €364.7M (-2.2% YoY); EBITDA: €35.5M (-38.5% YoY); net profit: €5.6M (-60.3% YoY).

Outlook and guidance

• Global pulp market dynamics improved in 2026, with Asian demand supporting price recovery.

• DP segment shows sustained recovery, with prices and demand rising, especially in Asia.

• Full ramp-up of Biotek’s DP conversion and Caima’s acetic acid/furfural project expected by year-end.

• Profitability expected to recover further as storm impacts on wood supply diminish.